BenevolentAI
therapy area and business model rationale competitive commercial scientific commercial clinical development data core therapeutic areas clinical development development out license at phase i or phase scientific strategy out license prior to phase i non core therapeutic areas collaborations non commercial collaborations | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
31 of 46
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Day
September 2022
therapy area and business model rationale competitive commercial scientific commercial clinical development data core therapeutic areas clinical development development out license at phase i or phase scientific strategy out license prior to phase i non core therapeutic areas collaborations non commercial collaborations | BenevolentAI
Related slides by other companies
Freeman Capital Management
Activist
May 2023
flawed clinical development strategy | Freeman Capital Management
Petco
Investor Day
March 2022
investing drive growth priority projected annual spend investment areas core invest vet pet care centers supply chain digital innovate committed to achieving well above hurdle rate returns rural vital care | Petco
Cytek
Investor Day
June 2022
today focus areas | Cytek
Lion Electric
Investor Event
September 2021
commercial | Lion Electric
Other recent decks by BenevolentAI
See all presentations (11 decks)
Investor Presentation
September 2024
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights